Status:
COMPLETED
Pain Therapy After Elective Cardiac Surgery
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Collaborating Sponsors:
German Federal Ministry of Education and Research
Conditions:
Pain
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine generation of a target controlled infusion model for the patient controlled analgesia with the strong analgesic, hydromorphone, after planned open heart surge...
Eligibility Criteria
Inclusion
- Written informed consent,
- Ability to understand the nature of patient-controlled analgesia and other study-specific procedures,
- Elective cardiac surgery with thoracotomy and subsequent stay in the intensive care unit
Exclusion
- Use of MAO inhibitors in the last 14 days,
- Chronic alcoholism or drug addiction in medical history,
- Severe obstructive or restrictive pulmonal disorders in medical history,
- Severe hepatic and renal disorders in medical history,
- Hypothyroidism, pancreatitis in medical history,
- ASA IV,
- Pregnant or nursing females
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01490268
Start Date
November 1 2011
End Date
September 1 2012
Last Update
December 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, University Hospital
Erlangen, Germany